Phase I Study of BL0020, a Novel Anti-tumor Drug, in Adult Subjects With Advanced Solid Tumors
Clinical trial NCT05886868 · UNKNOWN
Trial details
- NCT number
- NCT05886868
- Sponsor
- Shanghai Best-Link Bioscience, LLC
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-24
- Primary completion
- 2024-07-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.